Author Affiliations: Departments of Emergency Medicine (Dr Smithson), Internal Medicine (Dr Ramos), and Laboratory of Microbiology (Dr Bastida), Fundació Hospital de l’Esperit Sant, Santa Coloma de Gramenet, Barcelona, Spain.
We have read the article by Drekonja et al1 in which the authors evaluate the treatment patterns and outcomes in male patients with urinary tract infection (UTI) in the outpatient setting. The most relevant conclusion of the study is that a longer-duration antimicrobial treatment (>7 days) in men with UTI is not associated with a reduction of the recurrence rate compared with shorter-course treatments (≤7 days). So according to the study, is it time to redefine the most adequate duration of antimicrobial treatment in men with UTI? Our answer is no, at least not yet.
Smithson A, Ramos J, Bastida MT. Time to Redefine the Duration of Antimicrobial Treatment in Male Patients With Urinary Infections. JAMA Intern Med. 2013;173(12):1153–1154. doi:10.1001/jamainternmed.2013.973
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.